Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Commitments and Contingencies (Details Textual)

v3.21.2
Note 10 - Commitments and Contingencies (Details Textual) - USD ($)
Jun. 23, 2021
May 27, 2021
Mar. 16, 2021
Nov. 02, 2017
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance         $ 4,133,994 $ 6,436,170 $ 5,008,882 $ 2,046,907 $ 901,181 $ (1,622,715) $ (1,091,039) $ (880,989)
Market Capitalization, Fair Value         $ 52,800,000              
Ohio Court of Common Pleas [Member]                        
Litigation Settlement, Reversal of Amount Awarded from Other Party     $ 4,300,000                  
Platinum-Montaur Life Sciences LLC Litigation [Member] | Pending Litigation [Member]                        
Loss Contingency, Damages Sought, Value       $ 1,900,000                
New York Litigation Involving Former CEO and President [Member] | Judicial Ruling [Member]                        
Litigation Settlement, Amount Can Be Awarded to Other Party for Indemnification for Attorneys’ Fees   $ 14,955                    
Litigation Settlement, Amount Can Be Advanced to Other Party for Attorneys’ Fees Subject to Repayment   $ 1,237.50                    
Delaware Litigation Involving Former CEO and President [Member] | Judicial Ruling [Member]                        
Loss Contingency, Damages Sought, Value $ 70,000